Nanopharmaceuticals: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume One, examines the fabrication, optimization, scale-up, biological aspects, regulatory and clinical success of drug delivery systems. Reduced toxicity, industrial scale up, and in vivo success stories are featured in the book. Written by a diverse range of international researchers, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. Giving an overview of clinical statuses of drug delivery systems at advanced stages of development, this book covers academic DDS research and can be used by industrial scientists to review next steps.
This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it is a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.
- Encompasses all aspects of drug delivery systems
- Presents real world case studies to illustrate each step of the process
- Contains in-depth investigation of specific aspects of drug delivery systems
Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers
- Product development or formulation scientists
2. Scale up (engineering aspect) experts
3. Regulatory experts
4. Clinical experts
5. Patent -IP angle (tbd)
- No. of pages:
- © Elsevier 2020
- 3rd January 2020
- Paperback ISBN:
Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 7 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Head of Formulation Development Department at Symrise AG, Germany. She has authored more than 45 research articles, 20 book chapters, and 150 research abstracts. She has filed two patent applications on nanoparticles for targeting malaria and HIV/AIDS reservoirs and have 12 other patent application in area of active delivery. She is a recipient of several national and international awards for her research. Her areas of interest are oral solid dosage forms, dermal formulations, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, and galenic formulations.
Head, Formulation Development Department, Symrise AG, Germany